名臣健康(002919) - 2019 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2019 was ¥111,161,911.79, a decrease of 6.31% compared to ¥118,647,983.86 in the same period last year[7] - Net profit attributable to shareholders was ¥8,568,054.69, down 1.46% from ¥8,695,399.38 year-on-year[7] - The net profit after deducting non-recurring gains and losses increased by 11.22% to ¥8,573,706.00 from ¥7,709,063.14 in the previous year[7] - Total operating revenue for Q1 2019 was CNY 111,161,911.79, a decrease of 6.3% compared to CNY 118,647,983.86 in the previous period[35] - Net profit for Q1 2019 was CNY 8,568,054.69, slightly down from CNY 8,695,399.38 in the previous period, representing a decrease of 1.5%[37] - The net profit for the first quarter of 2019 was CNY 10,132,717.10, a slight decrease from CNY 10,181,215.54 in the same period last year, representing a decline of approximately 0.48%[41] - Operating profit for the first quarter was CNY 11,281,732.54, down from CNY 12,788,978.59, indicating a decrease of about 11.77% year-over-year[41] Cash Flow and Assets - The net cash flow from operating activities was -¥69,511,979.59, a decline of 18.05% compared to -¥58,882,518.04 in the same period last year[7] - Cash and cash equivalents decreased to CNY 111,233,551.61 from CNY 131,384,653.27, representing a decline of about 15.3%[26] - The net cash flow from operating activities was negative CNY 69,511,979.59, worsening from negative CNY 58,882,518.04 in the same quarter last year[45] - Cash inflow from investment activities totaled CNY 224,343,485.68, while cash outflow was CNY 174,982,607.75, resulting in a net cash flow of CNY 49,360,877.93 from investment activities[46] - The ending balance of cash and cash equivalents was 93,951,782.44, down from 113,769,975.09 at the beginning of the quarter[50] Assets and Liabilities - Total assets at the end of the reporting period were ¥657,152,029.12, a decrease of 1.99% from ¥670,497,117.53 at the end of the previous year[7] - The company's current assets totaled CNY 574,727,889.66, down from CNY 620,180,344.24 at the end of 2018, indicating a decline of approximately 7.34%[27] - Total liabilities decreased to CNY 97,688,039.10 from CNY 147,768,474.11, a reduction of approximately 33.9%[28] - Total assets decreased to CNY 631,845,784.50 from CNY 663,596,240.52, a decline of 4.8%[34] - Total liabilities decreased to CNY 64,827,557.74 from CNY 106,710,730.86, a significant reduction of 39.2%[33] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,150[10] - The largest shareholder, Chen Qinfang, holds 49.34% of the shares, amounting to 40,172,000 shares, with 15,500,000 shares pledged[10] - The net assets attributable to shareholders increased by 2.43% to ¥559,463,990.02 from ¥546,215,363.96 at the end of the previous year[7] - The company's equity attributable to shareholders increased to CNY 559,463,990.02 from CNY 550,895,935.33, showing a growth of about 1.03%[29] Operating Costs and Expenses - Total operating costs for Q1 2019 were CNY 103,501,542.29, down 5.6% from CNY 109,643,719.91 in the previous period[35] - The company incurred operating expenses of CNY 177,951,507.29, compared to CNY 158,559,610.08 in the same period last year, marking an increase of approximately 12.36%[45] - Research and development expenses increased to CNY 3,612,961.52, up 29.3% from CNY 2,794,180.67 in the previous period[35] Other Information - The company reported no overdue commitments from controlling shareholders or related parties during the reporting period[16] - There were no violations regarding external guarantees during the reporting period[19] - The company did not engage in any research, communication, or interview activities during the reporting period[21] - The first quarter report was not audited[51]